O. Senkovich

发表

Biochemical and structural characterization of Cryptosporidium parvum Lactate dehydrogenase.

W. Cook, D. Chattopadhyay, O. Senkovich, 2015, International journal of biological macromolecules.

Crystal structure of Trypanosoma cruzi pteridine reductase 2 in complex with a substrate and an inhibitor.

L. DeLucas, N. Schormann, M. Carson, 2005, Journal of structural biology.

Phase separation by the polyhomeotic sterile alpha motif compartmentalizes Polycomb Group proteins and enhances their activity

Chongwoo A. Kim, N. Francis, E. Seif, 2020, Nature Communications.

Crystal Structure of Cryptosporidium parvum Pyruvate Kinase

W. Cook, D. Chattopadhyay, O. Senkovich, 2012, PloS one.

Lipophilic Antifolate Trimetrexate Is a Potent Inhibitor of Trypanosoma cruzi: Prospect for Chemotherapy of Chagas' Disease

D. Chattopadhyay, N. Garg, O. Senkovich, 2005, Antimicrobial Agents and Chemotherapy.

Helicobacter pylori AlpA and AlpB Bind Host Laminin and Influence Gastric Inflammation in Gerbils

Carolyn G. Conant, P. Adegboyega, R. Rhoads, 2011, Infection and Immunity.

Unique Host Iron Utilization Mechanisms of Helicobacter pylori Revealed with Iron-Deficient Chemically Defined Media

T. Testerman, D. McGee, O. Senkovich, 2010, Infection and Immunity.

Mechanisms of anionic detergent-induced hemolysis.

O. Senkovich, E. Chernitsky, 1998, General physiology and biophysics.

Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase.

N. Schormann, S. Velu, B. Chenna, 2010, Bioorganic & medicinal chemistry.

Structure of the catalytic domain of Plasmodium falciparum ARF GTPase-activating protein (ARFGAP).

W. Cook, D. Chattopadhyay, O. Senkovich, 2011, Acta crystallographica. Section F, Structural biology and crystallization communications.

Structure and role of BCOR PUFD in non-canonical PRC1 assembly and disease.

A. Hinck, Chongwoo A. Kim, V. Bardwell, 2020, Biochemistry.

Structure of Streptococcus agalactiae glyceraldehyde-3-phosphate dehydrogenase holoenzyme reveals a novel surface.

N. Schormann, D. Chattopadhyay, G. Ulett, 2014, Acta crystallographica. Section F, Structural biology communications.

An unexpected phosphate binding site in Glyceraldehyde 3-Phosphate Dehydrogenase: Crystal structures of apo, holo and ternary complex of Cryptosporidium parvum enzyme

W. Cook, D. Chattopadhyay, O. Senkovich, 2009, BMC Structural Biology.

Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism.

W. Cook, D. Chattopadhyay, D. Briles, 2007, Journal of molecular biology.

Trypanosoma cruzi genome encodes a pteridine reductase 2 protein.

N. Schormann, D. Chattopadhyay, B. Pal, 2003, Molecular and biochemical parasitology.

Short communication Trypanosoma cruzigenome encodes a pteridine reductase 2 protein

N. Schormann, D. Chattopadhyay, B. Pal, 2003 .

Plasmodium falciparum ARFGAP: expression and crystallization of the catalytic domain.

D. Chattopadhyay, O. Senkovich, 2004, Biochimica et biophysica acta.

Chlamydia trachomatis glyceraldehyde 3‐phosphate dehydrogenase: Enzyme kinetics, high‐resolution crystal structure, and plasminogen binding

N. Schormann, D. Chattopadhyay, G. Ulett, 2020, Protein science : a publication of the Protein Society.

Crystallization of three key glycolytic enzymes of the opportunistic pathogen Cryptosporidium parvum.

D. Chattopadhyay, G. Zhu, K. Bradley, 2005, Biochimica et biophysica acta.

Structure‐based approach to pharmacophore identification, in silico screening, and three‐dimensional quantitative structure–activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function

A. Anderson, N. Schormann, D. Chattopadhyay, 2008, Proteins.

Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.

N. Schormann, D. Chattopadhyay, O. Senkovich, 2009, Acta crystallographica. Section D, Biological crystallography.